LDNFIT 1.5MG

LDNFIT 1.5MG Specification

Dosage Form
1.5mg

Indication
Autoimmune Disorders Multiple Sclerosis (MS) Rheumatoid Arthritis Hashimoto s Thyroiditis Lupus Chronic Inflammatory Diseases Crohn s Disease Ulcerative Colitis Fibromyalgia Neurological Conditions Parkinson s Disease Amyotrophic Lateral Sclerosis (ALS) Autism Spectrum Disorders (ASD) Cancer Support Therapy (as an immune modulator) Chronic Pain Conditions Complex Regional Pain Syndrome (CRPS) Neuropathic Pain Long COVID / Post-Viral Syndrome Mental Health Conditions (investigational use) Depression PTSD Anxiety Note: LDN is not FDA-approved for these indications. Use is considered off-label and should be supervised by a qualified healthcare provider.

Salt Composition
Low dose naltrexone 1.5mg

Pacakaging (Quantity Per Box)
10x10

Origin of Medicine
Manufactured In: India Formulated By: Licensed pharmaceutical manufacturers under GMP/WHO-GMP certified facilities Form: Oral Capsules (typically 1.5 mg, 3 mg, or 4.5 mg) Pharmaceutical Grade: Yes For: Domestic & Export Markets

Drug Type
General Medicines

Ingredients
Low Dose Naltrexone (LDN) Capsules are specially formulated in strengths of 1.5mg, 3mg, and 4.5mg for use in immune modulation and chronic disease management. LDN is derived from the FDA-approved antagonist Naltrexone Hydrochloride, but at low doses, it exhibits powerful off-label benefits in reducing inflammation, regulating immune response, and supporting neurological function. These capsules are manufactured under strict GMP/WHO-GMP certified conditions using pharmaceutical-grade ingredients, making them suitable for both domestic and international markets.

Physical Form
Capsules

Function
Increase Immunity

Recommended For
Autoimmune Disorders Such as Multiple Sclerosis (MS), Rheumatoid Arthritis, Hashimoto s Thyroiditis, and Lupus Chronic Inflammatory Conditions Including Crohn s disease, ulcerative colitis, and fibromyalgia Chronic Pain Management Neuropathic pain, complex regional pain syndrome (CRPS), and fibromyalgia Cancer Support Therapy (Off-label use) As an immune modulator in certain cancer care protocols (investigational use) Neurological Disorders Parkinson s disease, ALS, and autism spectrum disorders (supportive therapy) Long COVID / Post-Viral Fatigue Syndrome (Emerging use) Helps in managing lingering inflammation and fatigue symptoms Mental Health Conditions Depression, anxiety, PTSD (under investigation for anti-inflammatory mental health support)

Dosage
1.5mg

Dosage Guidelines
Standard Adult Dosage: Typically ranges from 1.5mg to 4.5mg per day Most common maintenance dose: 4.5mg once daily at bedtime Initial Dosing Strategy: Start with 1.5mg once daily (usually at night) Increase gradually every 1 2 weeks based on tolerance and response: Week 1 2: 1.5mg Week 3 4: 3.0mg Week 5 onward: 4.5mg (maintenance) Time of Administration: Preferably taken at bedtime to align with endogenous endorphin production Pediatric Use: Dosage must be adjusted based on body weight and under strict medical supervision Special Considerations: May need to adjust dose in patients with liver impairment or autoimmune flare-ups Monitor for temporary sleep disturbances or vivid dreams during initial weeks Not for Use: In combination with medications risk of withdrawal or reduced efficacy Important: Low Dose Naltrexone is used off-label for many conditions. Always follow dosage as advised by a qualified healthcare provider.

Suitable For
Suitable For All

Quantity
10 Strip

Storage Instructions
Store in a cool, dry place Keep at temperature below 25 C (77 F) Protect from direct sunlight, moisture, and heat Keep in original packaging to protect from light Do not freeze Keep out of reach of children Follow the expiry date and discard unused tablets properly

LDNFIT 1.5MG Trade Information

Minimum Order Quantity
1 Box

FOB Port
Seller's Responsibilities: Under FOB, the seller handles all costs and responsibilities up to the point where the goods are loaded onto the designated ship at the named port of shipment. This includes packaging, export documentation, and export customs clearance. Buyer's Responsibilities: The buyer is responsible for the cost of marine freight transport, insurance, unloading at the destination port, and transportation from that port to the final destination. Risk Transfer: The risk of loss or damage to the goods transfers from the seller to the buyer once the goods are loaded on board the vessel at the port of shipment. Port of Loading: The specific port of loading is crucial and must be clearly indicated in the agreement (e.g., FOB Shanghai). FOB and Incoterms: FOB is one of the Incoterms (International Commercial Terms) published by the International Chamber of Commerce. It is specifically used for sea or inland waterway transport.

Payment Terms
Cash in Advance (CID)

Supply Ability
5000 Boxes Per Month

Delivery Time
2 Days

Sample Available
No

Sample Policy
Free samples available with shipping and taxes paid by the buyer

Packaging Details
Packaging Type: Alu-Alu Blister Pack Pack Size: 10 Strips of 10 Capsules Each (10x10) Total Capsules per Box: 100 Capsules Primary Packaging Material: Aluminum foil

Main Export Market(s)
Asia, Australia, Central America, North America, South America

Main Domestic Market
All India

About LDNFIT 1.5MG

Low Dose Naltrexone (1.5mg):
Carefully formulated to deliver a consistent and accurate low dose of naltrexone, ideal for therapeutic benefits without the strong -blocking effects seen at higher doses (like 50mg).

2. Immunomodulatory Action:
Believed to helpregulate immune functionby increasing endogenous endorphin production, which can reduce inflammation and support immune balance in chronic conditions.